Agenda

March 11, Day 1

OPENING PROCEDURES

Please note this link is only for Day 1. Please see Day 2 for the March 12th link.

Link for attendees: https://nih.webex.com/nih/onstage/g.php?MTID=e378963df7045ccb4551d2995a0cb8db3

8:00 a.m. Portal Opens
8:30 – 8:35 a.m. Welcoming Remarks
Haiming Cao, PhD
National Heart, Lung, and Blood Institute, National Institutes of Health

Session I: LncRNAs: Basic Mechanism to Disease

Session Moderators: Haiming Cao, PhD and Elizabeth Murphy, PhD

8:35 – 9:15 a.m. Keynote: Long noncoding RNAs: past, present, and future
Jeannie T. Lee, PhD, Massachusetts General Hospital
9:15 – 9:45 a.m. LncRNA regulation of lipid metabolism and inflammation
Kathryn J. Moore, PhD, New York University
9:45 – 10:15 a.m. Linking lncRNAs with inflammation and fibrosis in diabetic complications
Rama Natarajan, PhD, Beckman Research Institute of City of Hope
10:15 – 10:30 a.m. BREAK
10:30 – 11:00 a.m. In vivo functional analysis of non-conserved human lncRNAs associated with cardiometablic rates
Haiming Cao, PhD, National Heart, Lung, and Blood Institute, National Institutes of Health
11:00 – 11:30 a.m. Challenges in translation of lncRNAs to human disease
Muredach Reilly, MBBCh, MSCE, Columbia University
11:30 – 12:00 p.m. LncRNA regulation of pancreatic islet cell functions
Lori Sussel, PhD, University of Colorado 12:00 – 12:30 p.m. Pitch Presentations
12:30 – 1:30 p.m. BREAK

SESSION II: Non-coding RNAs, Genetics and Disease

Moderators: Michael Sack, MD, PhD; Ashish Lal, PhD

1:30 – 2:00 p.m. A thrifty micro RNA linked to human positive selection and metabolic diseases
Anders Näär, PhD, University of California, Berkeley
2:00 – 2:30 p.m. Noncoding RNAs in human populations
Jane E. Freedman, MD, University of Massachusetts
2:30 – 3:00 p.m. miR-33 in cardiometabolic diseases
Carlos Fernandez-Hernando, PhD, Yale University
3:00 – 3:15 p.m. BREAK
3:15 – 3:45 p.m. LncRNA-mediated control of vascular senescence and atherosclerosis
Mark W. Feinberg, MD, Brigham and Women’s Hospital
3:45 – 4:15 p.m. High throughput identification of smooth muscle cell lncRNAs and their association with transcription and disease risk in this cell type
Thomas Quertermous, MD, Stanford University
4:15 – 4:45 p.m. Lnc’ing non-coding RNA function to bone marrow failure
Carl D. Novina, MD, PhD, Harvard Medical School
4:45 – 5:15 p.m. Pitch Presentations
5:30 – 7:00 p.m. Virtual Poster Session: https://spatial.chat/s/NHLBIlncRNA2021

March 12, Day 2

8:00 a.m. Portal Opens
8:30 – 8:35 a.m. Opening Remarks

SESSION III: LncRNAs: Development, Differentiation, and Disease

Link for attendees: https://nih.webex.com/nih/onstage/g.php?MTID=e082d531552f2d6bffa5583433fb1f63b

Moderators: Myriam Gorospe, PhD; Paul Hwang, MD, PhD

8:35 – 9:15 a.m. Keynote: How do noncoding RNAs regulate other RNAs and RNA binding proteins?
Joshua Mendell, MD, PhD, University of Texas Southwestern
9:15 – 9:45 a.m. Explore the role of non-coding RNAs in adipose tissue
Sun Lei, PhD, Duke-NUS Graduate Medical School
9:45 – 10:15 a.m. Molecular dissection of dual mechanisms in a lncRNA subclass
Daniel A. Lim, MD, PhD, University of California, San Francisco
10:15 – 10:30 a.m. BREAK
10:30 – 11:00 a.m. LncRNAs in cancer and differentiation: DRAIC and MUNC
Anindya Dutta, MD, PhD, University of Virginia School of Medicine
11:00 – 11:30 a.m. Function of noncoding RNA genome in cell cycle progression and cancer
Kannanganattu V. Prasanth, PhD, University of Illinois
11:30 – 12:00 p.m. Long noncoding RNAs in liver glucose homeostasis and metabolic disease
Jan-Wilhelm Kornfeld, PhD, University of Southern Denmark
12:00 – 12:30 p.m. Pitch Presentations
12:30 – 12:35 p.m. Closing Remarks
Robert S. Balaban, PhD
National Heart, Lung, and Blood Institute, National Institutes of Health